Blog
130 Articles
A New Triple Combination for Tumors with BRCA1/2 or PALB2 Mutations
A clinical trial is comparing a two-drug combination with a three-drug combination to see which works better for genetic mutations.
Leaning into the Fight: My Battle with Pancreatic Cancer
Despite an extensive family history of pancreatic cancer, Deanna Burney’s doctors did not keep a close eye on her pancreatic cyst.
Using Ultrasound to Enhance the Effectiveness of Chemotherapy
A clinical trial combines ultrasound with a microbubble contrast agent to make chemotherapy more effective.
Sometimes Things Get Worse Before They Get Better
Matthew Rosenblum thought his time was limited after a pancreatic cancer diagnosis at age 32, but he’s a BRCA2 carrier, which opened treatment options.
Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer
Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.
New FDA Approval Brings More Treatment Options in Metastatic Disease
The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.
A New Immunotherapy Drug to Make Chemotherapy More Effective for Metastatic Pancreatic Cancer
Researchers are testing a new immunotherapy drug to make standard chemotherapy more effective for metastatic pancreatic cancer.
Always Insist On More
Dave Paffenroth’s wife Wendy was an extraordinary caregiver, coordinating treatments and family support during pancreatic cancer treatment.
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
A New Approach to Immunotherapy for Advanced Pancreatic Cancer
Will a new type of immunotherapy help prevent tumors from developing resistance to chemotherapy? Research is underway.
A Family Tree Bent but Not Broken by Pancreatic Cancer
When Kay Zedd Kesser looks around her family tree, she sees pancreatic cancer everywhere. But screening saved Kay’s life.
Potential Therapy Takes a Two-Prong Attack on Pancreatic Cancer
With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.
Changing Course Midstream
Barbara Green wasn’t happy with her doctors, so she took the advice of her support group, was an advocate for herself, and changed doctors.
Testing the Addition of a New Drug to Radiation Therapy for Localized Pancreatic Cancer
In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.
Genetic Profiling Leads to a Clinical Trial
With treatment not working and nothing to lose, Cathleen Janosko did her research and got help finding a clinical trial to match her tumor’s mutation.